Abstract:Objective To investigate the expression of HMBOX1 (Homeobox containing 1) in prostate cancer and its effect on epithelial-mesenchymal transition. Methods Totally 68 patients with prostate cancer who underwent concurrent radical prostatectomy in our hospital from October 2015 to October 2017 were selected as subjects (PC group), and 70 patients with benign prostatic hyperplasia admitted to the same period were selected as the control (BPH group); immunohistochemistry was used to detect the expression of HMBOX1 in PC and BPH groups; the HMBOX1 overexpression (experimental group) and control stable cell lines were constructed; western blot was used to detect the expression of HMBOX1, E-cadherin and Vimentin, and the wound-healing assay was used to detect the effect of HMBOX1 overexpression on cell migration; the effect of HMBOX1 overexpression on cell migration was analyzed by Transwell assay. Results Compared with BPH group (55.71%), the positive expression rate of HMBOX1 protein in PC group (19.12%) was decreased. The difference was statistically significant (P?0.05). Western blotting showed that the expression level of E-cadherin in experimental group was higher than that in control group (P?0.05) and the expression level of Vimentin was significantly lower than that in control group (P?0.05). Wound-healing assay showed that, compared with the control cells, the wound healing area of the experimental group was smaller after 24?h, and the migration rate was decreased. The difference was statistically significant (P?0.05). Transwell assay showed a decrease in the number of invasive cells in experimental group (172.06?±?19.25) compared with control group (421.88?±?45.70) (P?0.05). Conclusion The expression of HMBOX1 is significantly decreased in prostate cancer tissues. Overexpression of HMBOX1 significantly inhibit the epithelial-mesenchymal transition and tumor migration of prostate cancer.